Back to Search
Start Over
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
- Authors :
- Burgess, Stephen
Ference, Brian A.
Staley, James R.
Freitag, Daniel F.
Mason, Amy M.
Nielsen, Sune F.
Willeit, Peter
Young, Robin
Surendran, Praveen
Karthikeyan, Savita
Bolton, Thomas R.
Peters, James E.
Kamstrup, Pia R.
Tybjærg-Hansen, Anne
Benn, Marianne
Langsted, Anne
Schnohr, Peter
Vedel-Krogh, Signe
Kobylecki, Camilla J.
Ford, Ian
Packard, Chris
Trompet, Stella
Jukema, J. Wouter
Sattar, Naveed
Di Angelantonio, Emanuele
Saleheen, Danish
Howson, Joanna M. M.
Nordestgaard, Børge G.
Butterworth, Adam S.
Danesh, John
Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom
MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark
The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark
Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen University Hospital, Copenhagen, Denmark
Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom
Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom
Department of Cardiology, Leiden University Medical Centre, Leiden, the Netherlands
Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
- Publication Year :
- 2018
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.narcis........9915f6ac3b8458e109244d3a434b38ad